Table of Content

1 NGS-based RNA-seq Market Introduction and Overview
1.1 NGS-based RNA-seq Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global NGS-based RNA-seq Sales and Market Share by Manufacturer
2.2 Global NGS-based RNA-seq Revenue and Market Share by Manufacturer
2.3 Global NGS-based RNA-seq Average Price by Manufacturers
2.4 Manufacturers NGS-based RNA-seq Production Sites, Area Served, Product Types
2.5 NGS-based RNA-seq Market Competitive Situation and Trends
2.5.1 NGS-based RNA-seq Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.5.3 Mergers & Acquisitions, Expansion
3 Global NGS-based RNA-seq Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global NGS-based RNA-seq Market Share by Type 2018 VS 2022
3.2 Global NGS-based RNA-seq Revenue and Market Share by Type
3.3 Global NGS-based RNA-seq Sales and Market Share by Type
4 Global NGS-based RNA-seq Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global NGS-based RNA-seq Market Share by Application 2018 VS 2022
4.2 Global NGS-based RNA-seq Revenue Market Share by Application (2018-2023)
4.3 Global NGS-based RNA-seq Sales Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global NGS-based RNA-seq Market Size (2018-2023)
5.2 NGS-based RNA-seq Growth Trends Analysis by Regions
5.2.1 NGS-based RNA-seq Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 NGS-based RNA-seq Historic Revenue Market Size by Regions (2018-2023)
5.2.3 NGS-based RNA-seq Historic Sales Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America NGS-based RNA-seq Revenue by Countries (2018-2023)
5.3.2 North America NGS-based RNA-seq Sales by Countries (2018-2023)
5.3.3 North America SWOT Analysis
5.3.4 United States
5.3.5 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific NGS-based RNA-seq Revenue by Countries (2018-2023)
5.5.2 Asia Pacific NGS-based RNA-seq Sales by Countries (2018-2023)
5.5.3 Asia Pacific SWOT Analysis
5.5.4 Japan
5.5.5 Korea
5.5.6 Southeast Asia
5.5.7 India
5.5.8 Australia
5.6 EMEA
5.6.1 EMEA NGS-based RNA-seq Revenue by Countries (2018-2023)
5.6.2 EMEA NGS-based RNA-seq Sales by Countries (2018-2023)
5.6.3 EMEA SWOT Analysis
5.6.4 Europe
5.6.5 Middle East
5.6.6 Africa
5.7 Latin America
5.7.1 Latin America NGS-based RNA-seq Revenue by Countries (2018-2023)
5.7.2 Latin America NGS-based RNA-seq Sales by Countries (2018-2023)
5.7.3 Latin America SWOT Analysis
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Mexico
6 Players Profiles
6.1 Illumina
6.1.1 Illumina Company Profile
6.1.2 NGS-based RNA-seq Product Overview
6.1.3 Illumina NGS-based RNA-seq Market Performance (2018-2023)
6.1.4 Illumina Business Overview
6.1.5 SWOT Analysis
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Company Profile
6.2.2 NGS-based RNA-seq Product Overview
6.2.3 Thermo Fisher Scientific NGS-based RNA-seq Market Performance (2018-2023)
6.2.4 Thermo Fisher Scientific Business Overview
6.2.5 SWOT Analysis
6.3 Pacific Biosciences Of California
6.3.1 Pacific Biosciences Of California Company Profile
6.3.2 NGS-based RNA-seq Product Overview
6.3.3 Pacific Biosciences Of California NGS-based RNA-seq Market Performance (2018-2023)
6.3.4 Pacific Biosciences Of California Business Overview
6.3.5 SWOT Analysis
6.4 Qaigen
6.4.1 Qaigen Company Profile
6.4.2 NGS-based RNA-seq Product Overview
6.4.3 Qaigen NGS-based RNA-seq Market Performance (2018-2023)
6.4.4 Qaigen Business Overview
6.4.5 SWOT Analysis
6.5 F. Hoffmann-La Roche
6.5.1 F. Hoffmann-La Roche Company Profile
6.5.2 NGS-based RNA-seq Product Overview
6.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Market Performance (2018-2023)
6.5.4 F. Hoffmann-La Roche Business Overview
6.5.5 SWOT Analysis
6.6 Agilent Technologies
6.6.1 Agilent Technologies Company Profile
6.6.2 NGS-based RNA-seq Product Overview
6.6.3 Agilent Technologies NGS-based RNA-seq Market Performance (2018-2023)
6.6.4 Agilent Technologies Business Overview
6.6.5 SWOT Analysis
6.7 Oxford Nanopore Technologies
6.7.1 Oxford Nanopore Technologies Company Profile
6.7.2 NGS-based RNA-seq Product Overview
6.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Market Performance (2018-2023)
6.7.4 Oxford Nanopore Technologies Business Overview
6.7.5 SWOT Analysis
6.8 Perkinelmer
6.8.1 Perkinelmer Company Profile
6.8.2 NGS-based RNA-seq Product Overview
6.8.3 Perkinelmer NGS-based RNA-seq Market Performance (2018-2023)
6.8.4 Perkinelmer Business Overview
6.8.5 SWOT Analysis
6.9 Eurofins Scientific
6.9.1 Eurofins Scientific Company Profile
6.9.2 NGS-based RNA-seq Product Overview
6.9.3 Eurofins Scientific NGS-based RNA-seq Market Performance (2018-2023)
6.9.4 Eurofins Scientific Business Overview
6.9.5 SWOT Analysis
6.10 Gatc Biotech
6.10.1 Gatc Biotech Company Profile
6.10.2 NGS-based RNA-seq Product Overview
6.10.3 Gatc Biotech NGS-based RNA-seq Market Performance (2018-2023)
6.10.4 Gatc Biotech Business Overview
6.10.5 SWOT Analysis
6.11 Macrogen
6.11.1 Macrogen Company Profile
6.11.2 NGS-based RNA-seq Product Overview
6.11.3 Macrogen NGS-based RNA-seq Market Performance (2018-2023)
6.11.4 Macrogen Business Overview
6.11.5 SWOT Analysis
7 NGS-based RNA-seq Manufacturing Cost Analysis
7.1 NGS-based RNA-seq Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of NGS-based RNA-seq
7.4 NGS-based RNA-seq Industrial Chain Analysis
8 Market Channel, Distributors, Traders and Dealers
8.1 Market Channel Status
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.2 NGS-based RNA-seq Typical Distributors
8.3 NGS-based RNA-seq Typical Customers
9 NGS-based RNA-seq Industry Dynamic Analysis
9.1 NGS-based RNA-seq Market Trends Analysis
9.2 NGS-based RNA-seq Market Drivers Analysis
9.3 NGS-based RNA-seq Market Challenges Analysis
9.4 NGS-based RNA-seq Market Restraints Analysis
10 Global NGS-based RNA-seq Forecast Market Analysis by Type & Application
10.1 Global NGS-based RNA-seq Revenue Market Forecast by Type (2023-2029)
10.2 Global NGS-based RNA-seq Sales Market Forecast by Type (2023-2029)
10.3 NGS-based RNA-seq Revenue Market Forecast by Application (2023-2029)
10.4 NGS-based RNA-seq Sales Market Forecast by Application (2023-2029)
11 Global NGS-based RNA-seq Forecast Market Analysis by Region
11.1 NGS-based RNA-seq Revenue Market Forecast by Region (2023-2029)
11.2 NGS-based RNA-seq Sales Market Forecast by Region (2023-2029)
11.3 North America NGS-based RNA-seq Forecast Market Analysis
11.4 EMEA NGS-based RNA-seq Forecast Market Analysis
11.5 China NGS-based RNA-seq Forecast Market Analysis
11.6 Asia-Pacific NGS-based RNA-seq Forecast Market Analysis
11.7 Latin America NGS-based RNA-seq Forecast Market Analysis
12 Research Findings and Conclusion